Omeros' long term data of phase 2 trial of narsoplimab shows benefit in kidney disorder
November 05 2021 - 9:34AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Omeros (NASDAQ:OMER)
Historical Stock Chart
From Mar 2024 to Apr 2024
Omeros (NASDAQ:OMER)
Historical Stock Chart
From Apr 2023 to Apr 2024